Saturday, July 06, 2019 12:00:23 PM
If anything the reasons fall short as corporate XXII has either failed to promote their I/Ps or they have not met the cut for BT or the Cannibus, Hemp, and Cannibidol areas that corporate has promoted for years. What successful role has XXII's subsidiary Botanical Genetics achieved to date that has produced positive results to date?
To date nothing but smoke and mirrors, excuse the smoke from corporate. All of which have taken off without XXII TO DATE. Thus the stagnated share pricing of the company with nothing to show their shareholders. This scenario has been playing for years as stated earlier. Wash rinse repeat!
Great job Henry and crew!!!
Recent XXII News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/01/2024 09:15:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/25/2024 09:15:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 10:05:22 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/23/2024 11:27:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/15/2024 09:20:35 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/15/2024 01:09:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 09:43:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 01:07:12 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/09/2024 01:58:17 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/08/2024 11:23:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 12:00:18 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 10/04/2024 08:53:44 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/01/2024 01:20:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 01:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 10:44:03 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/25/2024 09:00:31 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 10:21:11 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/16/2024 09:26:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 05:31:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:14:57 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 09/05/2024 08:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 01:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 01:00:13 PM
- Form 253G3 - • Edgar (US Regulatory) • 08/16/2024 09:27:31 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM